258 related articles for article (PubMed ID: 19733604)
21. The impact of vehicle on assessment of relative skin sensitization potency of 1,4-dihydroquinone in the local lymph node assay.
Lea LJ; Warbrick EV; Dearman RJ; Kimber I; Basketter DA
Am J Contact Dermat; 1999 Dec; 10(4):213-8. PubMed ID: 10594297
[TBL] [Abstract][Full Text] [Related]
22. Assessment of the skin sensitising potency of the lower alkyl methacrylate esters.
Kimber I; Pemberton MA
Regul Toxicol Pharmacol; 2014 Oct; 70(1):24-36. PubMed ID: 24956587
[TBL] [Abstract][Full Text] [Related]
23. Methyldibromoglutaronitrile: skin sensitization and quantitative risk assessment.
Basketter DA
Cutan Ocul Toxicol; 2010 Mar; 29(1):4-9. PubMed ID: 19883218
[TBL] [Abstract][Full Text] [Related]
24. Contact and respiratory sensitizers can be identified by cytokine profiles following inhalation exposure.
De Jong WH; Arts JH; De Klerk A; Schijf MA; Ezendam J; Kuper CF; Van Loveren H
Toxicology; 2009 Jul; 261(3):103-11. PubMed ID: 19422874
[TBL] [Abstract][Full Text] [Related]
25. The local lymph node assay compared with the human maximization test as an indicator of allergic potency in humans using patch test clinic populations.
Zaghi D; Maibach HI
Cutan Ocul Toxicol; 2009; 28(2):61-4. PubMed ID: 19514928
[TBL] [Abstract][Full Text] [Related]
26. A future approach to measuring relative skin sensitising potency: a proposal.
Jowsey IR; Basketter DA; Westmoreland C; Kimber I
J Appl Toxicol; 2006; 26(4):341-50. PubMed ID: 16773645
[TBL] [Abstract][Full Text] [Related]
27. Prediction of skin sensitization potency of chemicals by human Cell Line Activation Test (h-CLAT) and an attempt at classifying skin sensitization potency.
Nukada Y; Ashikaga T; Miyazawa M; Hirota M; Sakaguchi H; Sasa H; Nishiyama N
Toxicol In Vitro; 2012 Oct; 26(7):1150-60. PubMed ID: 22796097
[TBL] [Abstract][Full Text] [Related]
28. Use of the local lymph node assay for the estimation of relative contact allergenic potency.
Basketter DA; Balikie L; Dearman RJ; Kimber I; Ryan CA; Gerberick GF; Harvey P; Evans P; White IR; Rycroft RJ
Contact Dermatitis; 2000 Jun; 42(6):344-8. PubMed ID: 10871098
[TBL] [Abstract][Full Text] [Related]
29. The use of ethanol:diethylphthalate as a vehicle for the local lymph node assay.
Betts CJ; Beresford L; Dearman RJ; Lalko J; Api AP; Kimber I
Contact Dermatitis; 2007 Feb; 56(2):70-5. PubMed ID: 17244073
[TBL] [Abstract][Full Text] [Related]
30. Local lymph node assay: validation assessment for regulatory purposes.
Gerberick GF; Ryan CA; Kimber I; Dearman RJ; Lea LJ; Basketter DA
Am J Contact Dermat; 2000 Mar; 11(1):3-18. PubMed ID: 10684384
[TBL] [Abstract][Full Text] [Related]
31. The reduced local lymph node assay: the impact of group size.
Ryan CA; Chaney JG; Kern PS; Patlewicz GY; Basketter DA; Betts CJ; Dearman RJ; Kimber I; Gerberick GF
J Appl Toxicol; 2008 May; 28(4):518-23. PubMed ID: 17879259
[TBL] [Abstract][Full Text] [Related]
32. Use of an ex vivo local lymph node assay to assess contact hypersensitivity potential.
Piccotti JR; Kawabata TT
J Immunotoxicol; 2008 Jul; 5(3):271-7. PubMed ID: 18830887
[TBL] [Abstract][Full Text] [Related]
33. Skin irritation and sensitization: mechanisms and new approaches for risk assessment.
Basketter D; Darlenski R; Fluhr JW
Skin Pharmacol Physiol; 2008; 21(4):191-202. PubMed ID: 18509253
[TBL] [Abstract][Full Text] [Related]
34. Effect of Prolonged Repeated Exposure to Formaldehyde Donors with Doses Below the EC3 Value on Draining Lymph Node Responses.
De Jong WH; De Klerk A; Beek MT; Veenman C; Van Loveren H
J Immunotoxicol; 2007 Jul; 4(3):239-46. PubMed ID: 18958734
[TBL] [Abstract][Full Text] [Related]
35. Proliferative responses in the local lymph node assay associated with concomitant exposure to 1,4-phenylenediamine and methyldibromo glutaronitrile: evidence for synergy?
Jowsey IR; Basketter DA; Irwin A
Contact Dermatitis; 2008 Aug; 59(2):90-5. PubMed ID: 18759875
[TBL] [Abstract][Full Text] [Related]
36. Study of the sensitising potential of various textile dyes using a biphasic murine local lymph node assay.
Ahuja V; Platzek T; Fink H; Sonnenburg A; Stahlmann R
Arch Toxicol; 2010 Sep; 84(9):709-18. PubMed ID: 20585758
[TBL] [Abstract][Full Text] [Related]
37. Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 2. The biological variability of the murine Local Lymph Node Assay (LLNA) for skin sensitisation.
Roberts DW; Api AM; Aptula AO
Regul Toxicol Pharmacol; 2016 Oct; 80():255-9. PubMed ID: 27470439
[TBL] [Abstract][Full Text] [Related]
38. ICCVAM evaluation of the murine local lymph node assay. Conclusions and recommendations of an independent scientific peer review panel.
Dean JH; Twerdok LE; Tice RR; Sailstad DM; Hattan DG; Stokes WS
Regul Toxicol Pharmacol; 2001 Dec; 34(3):258-73. PubMed ID: 11754530
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the sensitization potential of persulfate salts used for bleaching hair.
Cruz MJ; De Vooght V; Muñoz X; Hoet PH; Morell F; Nemery B; Vanoirbeek JA
Contact Dermatitis; 2009 Feb; 60(2):85-90. PubMed ID: 19207378
[TBL] [Abstract][Full Text] [Related]
40. Skin sensitization: strategies for the assessment and management of risk.
Basketter DA
Br J Dermatol; 2008 Aug; 159(2):267-73. PubMed ID: 18503602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
